Mifepristone Improves Octreotide Efficacy in Resistant Ectopic Cushing's Syndrome

A 30-year-old Caucasian man presented with severe Cushing's syndrome (CS) resulting from ectopic adrenocorticotropin syndrome (EAS) from a metastatic pancreatic neuroendocrine tumor. The patient remained hypercortisolemic despite treatment with steroidogenesis inhibitors, chemotherapy, and octr...

Descripción completa

Detalles Bibliográficos
Autores principales: Moraitis, Andreas G., Auchus, Richard J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4773543/
https://www.ncbi.nlm.nih.gov/pubmed/26989527
http://dx.doi.org/10.1155/2016/8453801

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4773543/
https://www.ncbi.nlm.nih.gov/pubmed/26989527
http://dx.doi.org/10.1155/2016/8453801

Ejemplares similares